1. In vitro properties of antimicrobial bromotyrosine alkaloids
- Author
-
Junfa Fan, Jiong Lan, Yossef Av-Gay, Mamta Rawat, Dorit Arad, Andrew S. Kende, and Neora Pick
- Subjects
Microbiology (medical) ,Meticillin ,Fluoroacetates ,Biology ,medicine.disease_cause ,Microbiology ,Monocytes ,Cell Line ,Amidase ,chemistry.chemical_compound ,Alkaloids ,medicine ,Humans ,Bacteria ,Molecular Structure ,Macrophages ,Alkaloid ,General Medicine ,Antimicrobial ,biology.organism_classification ,In vitro ,Anti-Bacterial Agents ,Mycothiol ,Models, Chemical ,chemistry ,Biochemistry ,Staphylococcus aureus ,Tyrosine ,medicine.drug - Abstract
A bromotyrosine alkaloid family of antimicrobial agents was synthesized using the known structure of a natural inhibitor of the mycobacterial mycothiolS-conjugate amidase (MCA) as a template. This series of compounds represents a novel class of anti-infective agents against Gram-positive pathogens, including mycobacteria and meticillin- and vancomycin-resistantStaphylococcus aureus. The fact that these compounds are active against mycobacterial strains in which the MCA gene is deleted and against Gram-positive bacteria lacking mycothiol suggests the existence of an alternative target for these compounds. One member of this family, EXEG1706, was identified as the lead compound possessing low MICs (2·5–25 μg ml−1) for several clinical isolates, whilst having low toxicity for THP-1 monocytes and macrophages.
- Published
- 2006